 |
 |
|
Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
15 June 1993 | Volume 118 Issue 12 | Pages 947-953
Objective: To determine if patients with the Guillain-Barre syndrome are likely to have had Campylobacter jejuni infection before onset of neurologic symptoms.
Design: A case–control study.
Setting: Several university medical centers.
Patients: Case patients met clinical criteria for the Guillain-Barre syndrome between 1983 and 1990 and had a serum sample collected and frozen within 3 weeks after onset of neurologic symptoms (n = 118). Disease controls were patients with other neurologic illnesses (n = 56); healthy controls were hospital employees or healthy family members of patients (n = 47).
Measurements: Serum IgA, IgG, and IgM antibodies to C. jejuni were determined by enzyme-linked immunosorbent assays. Assays were done in a blinded manner.
Results: Optical density ratios
Conclusions: Patients with the Guillain-Barre syndrome are more likely than controls to have serologic evidence of C. jejuni infection in the weeks before onset of neurologic symptoms. Campylobacter jejuni may play a role in the initiation of the Guillain-Barre syndrome in many patients.
Author and Article Information
From Vanderbilt University School of Medicine and Veterans Affairs Medical Center, Nashville, Tennessee; University of Medicine and Dentistry of New Jersey Newark, New Jersey; University of Maryland School of Medicine, Baltimore, Maryland; St. Louis University, St. Louis, Missouri.
ARTICLE
Serologic Evidence of Previous Campylobacter jejuni Infection in Patients with the Guillain-Barre Syndrome
2 in two or more immunoglobulin classes were seen in 43 (36%) of patients with the Guillain-Barre syndrome and in 10 (10%) of controls (odds ratio, 5.3; 95% CI, 2.4 to 12.5; P < 0.001). Increasing the optical density ratio or the number of immunoglobulin classes necessary to yield a positive result increased the strength of the association. The number of patients with the Guillain-Barre syndrome who had positive serologic responses was greatest from September to November (P = 0.02). Male patients were three times more likely to have serologic evidence of C. jejuni infection (P = 0.009); the proportion of patients with the syndrome who had a positive serologic response increased with age.
Grant Support: In part by the Muscular Dystrophy Association, the U.S. Army Medical Research and Development Command, the Thrasher Research Fund, and the Medical Research Service of the Department of Veterans Affairs.
This article has been cited by other articles:
|
|
 |
|
  S. Baqar, L. A. Applebee, T. C. Gilliland Jr., L. H. Lee, C. K. Porter, and P. Guerry Immunogenicity and Protective Efficacy of Recombinant Campylobacter jejuni Flagellum-Secreted Proteins in Mice Infect. Immun., July 1, 2008; 76(7): 3170 - 3175. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Schmidt-Ott, H. Schmidt, S. Feldmann, F. Brass, B. Krone, and U. Gross Improved Serological Diagnosis Stresses the Major Role of Campylobacter jejuni in Triggering Guillain-Barre Syndrome. Clin. Vaccine Immunol., July 1, 2006; 13(7): 779 - 783. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Al-Mahmeed, A. C. Senok, A. Y. Ismaeel, K. M. Bindayna, K. S. Tabbara, and G. A. Botta Clinical relevance of virulence genes in Campylobacter jejuni isolates in Bahrain. J. Med. Microbiol., July 1, 2006; 55(Pt 7): 839 - 843. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. J. Golden and D. W. K. Acheson Identification of Motility and Autoagglutination Campylobacter jejuni Mutants by Random Transposon Mutagenesis Infect. Immun., April 1, 2002; 70(4): 1761 - 1771. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J B Winer Guillain Barre syndrome Mol. Pathol., December 1, 2001; 54(6): 381 - 385. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Koga, C W Ang, N Yuki, B C Jacobs, P Herbrink, F G A van der Meche, K Hirata, and P A van Doorn Comparative study of preceding Campylobacter jejuni infection in Guillain-Barre syndrome in Japan and The Netherlands J. Neurol. Neurosurg. Psychiatry, May 1, 2001; 70(5): 693 - 695. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. C. T. Carvalho, G. M. Ruiz-Palacios, P. Ramos-Cervantes, L.-E. Cervantes, X. Jiang, and L. K. Pickering Molecular Characterization of Invasive and Noninvasive Campylobacter jejuni and Campylobacter coli Isolates J. Clin. Microbiol., April 1, 2001; 39(4): 1353 - 1359. [Abstract] [Full Text]
|
|
|
|
 |
|
 R.D.M. Hadden, H. Karch, H.-P. Hartung, J. Zielasek, B. Weissbrich, J. Schubert, A. Weishaupt, D.R. Cornblath, A.V. Swan, R.A.C. Hughes, et al. Preceding infections, immune factors, and outcome in Guillain-Barre syndrome Neurology, March 27, 2001; 56(6): 758 - 765. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Seneviratne Guillain-Barre syndrome Postgrad. Med. J., December 1, 2000; 76(902): 774 - 782. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. M. Prendergast and A. P. Moran Review: Lipopolysaccharides in the development of the Guillain-Barre syndrome and Miller Fisher syndrome forms of acute inflammatory peripheral neuropathies Innate Immunity, October 1, 2000; 6(5): 341 - 359. [Abstract] [PDF]
|
|
|
|
 |
|
 B. Duim, C. W. Ang, A. van Belkum, A. Rigter, N. W. J. van Leeuwen, H. P. Endtz, and J. A. Wagenaar Amplified Fragment Length Polymorphism Analysis of Campylobacter jejuni Strains Isolated from Chickens and from Patients with Gastroenteritis or Guillain-Barre or Miller Fisher Syndrome Appl. Envir. Microbiol., September 1, 2000; 66(9): 3917 - 3923. [Abstract] [Full Text]
|
|
|
|
|
|
B. Duim, T. M. Wassenaar, A. Rigter, and J. Wagenaar High-Resolution Genotyping of Campylobacter Strains Isolated from Poultry and Humans with Amplified Fragment Length Polymorphism Fingerprinting Appl. Envir. Microbiol., June 1, 1999; 65(6): 2369 - 2375. [Abstract] [Full Text]
|
|
|
|
|
|
M. M. Prendergast, A. J. Lastovica, and A. P. Moran Lipopolysaccharides from Campylobacter jejuni O:41 Strains Associated with Guillain-Barre Syndrome Exhibit Mimicry of GM1 Ganglioside Infect. Immun., August 1, 1998; 66(8): 3649 - 3655. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Nachamkin, B. M. Allos, and T. Ho Campylobacter Species and Guillain-Barre Syndrome Clin. Microbiol. Rev., July 1, 1998; 11(3): 555 - 567. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E A Goddard, A J Lastovica, and A C Argent Campylobacter 0:41 isolation in Guillain-Barre syndrome Arch. Dis. Child., June 1, 1997; 76(6): 526 - 528. [Abstract] [Full Text]
|
|
|
|
|
|
A.P. Moran, B.J. Appelmelk, and G.O. Aspinall Review: Molecular mimicry of host structures by lipopolysaccharides of Campylobacter and Helicobacter spp.: implications in pathogenesis Innate Immunity, December 1, 1996; 3(6): 521 - 531. [Abstract] [PDF]
|
|
|
|
 |
|
 J. H. Rees, S. E. Soudain, N. A. Gregson, and R. A.C. Hughes Campylobacter jejuni Infection and Guillain-Barre Syndrome N. Engl. J. Med., November 23, 1995; 333(21): 1374 - 1379. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 CAMPYLOBACTER INFECTION AND GUILLAIN-BARRE SYNDROME Journal Watch (General), July 6, 1993; 1993(706): 3 - 3. [Full Text]
|
|
Article
